Original language | English |
---|---|
Pages (from-to) | S445-S446 |
Journal | European Neuropsychopharmacology |
Volume | 29 |
Publication status | Published - 1 Jan 2019 |
Neurogenesis deficits in Down syndrome: testing recovery with GABA alpha 5 negative allosteric modulator, beta 2 adrenergic agonist and IGF-1 in Ts65Dn mice.
C Albac, F Stagni, Mariagrazia GRILLI, ME Salvalai, R Bartesaghi, MC Potier
Research output: Contribution to journal › Article › peer-review